{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:19:01Z","timestamp":1790014741086,"version":"4.0.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.juro.2010.08.028","type":"journal-article","created":{"date-parts":[[2010,10,17]],"date-time":"2010-10-17T04:13:53Z","timestamp":1287288833000},"page":"2423-2428","source":"Crossref","is-referenced-by-count":71,"title":["Botulinum Toxin-A Injections Into Neurogenic Overactive Bladder\u2014To Include or Exclude the Trigone? A Prospective, Randomized, Controlled Trial"],"prefix":"10.1097","volume":"184","author":[{"given":"Taha A.","family":"Abdel-Meguid","sequence":"first","affiliation":[{"name":"Department of Urology, King Abdulaziz University Medical City, Jeddah, Saudi Arabia and Department of Urology, El-Minia University, El-Minia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2010.08.028_bib1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11934-002-0081-9","article-title":"Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction","volume":"3","author":"Smith","year":"2002","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.juro.2010.08.028_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox\u00ae) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S1677-55382007000200002","article-title":"Botulinum toxin injection: a review of injection principles and protocols","volume":"33","author":"Rapp","year":"2007","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","article-title":"Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results","volume":"50","author":"Patel","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report","volume":"55","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","article-title":"Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity","volume":"178","author":"Kuo","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib7","first-page":"412","article-title":"Trigonum and bladder base injection of botulinum toxin A (BTX) in patients with severe urgency-frequency syndrome refractory to conservative medical treatment and electrical stimulation","volume":"20","author":"Zermann","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2010.08.028_bib8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.juro.2007.07.120","article-title":"Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat","volume":"180","author":"Chuang","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2006.01.005","article-title":"Botulinum toxin\u2014new mechanisms, new therapeutic directions?","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib11","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-5347(17)42750-9","article-title":"Urge incontinence can be a disease of bladder sensors","volume":"139","author":"Klein","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","article-title":"Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies","volume":"21","author":"Schafer","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2010.08.028_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1520-6777(1999)18:2<139::AID-NAU9>3.0.CO;2-U","article-title":"The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures","volume":"18","author":"Stohrer","year":"1999","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2010.08.028_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2010.08.028_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs?","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2006.10.047","article-title":"Botulinum toxin type A injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux","volume":"177","author":"Karsenty","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib19","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","article-title":"Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity","volume":"68","author":"Karsenty","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.08.028_bib20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","article-title":"Do repeat intradetrusor botulinum toxin type A injections yield valuable results?","volume":"52","author":"Reitz","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.08.028_bib21","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","article-title":"Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity","volume":"53","author":"Apostolidis","year":"2008","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710042813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710042813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.08.028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T21:50:11Z","timestamp":1651182611000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.08.028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1016\/j.juro.2010.08.028"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.08.028","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.6930957.7121055","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}